Beijing Anzhen Hospital
4 clinical trials · 4 recruiting · OTHER
Trials by Beijing Anzhen Hospital
RECRUITINGNCT06987825
Chinese Atrial Fibrillation Registry
This prospective, observational cohort study aims to establish a long-term registry of adult patients with atrial fibrillation (AF) in China to comprehensively characterize...
Sponsor: Beijing Anzhen HospitalEnrolling: 1000002 locations
Atrial Fibrillation (AF)
RECRUITINGNCT07403760
Wellbeing and Survival Improvement With Event Reduction by Ablation for Atrial Fibrillation in the Very Elderly
The WISER-AF trial is a multicenter, double-blind, sham-controlled, randomized controlled trial. It aims to evaluate the efficacy and safety of catheter ablation compared to a...
Sponsor: Beijing Anzhen HospitalEnrolling: 1821 location
Atrial Fibrillation (AF)
RECRUITINGPhase 3NCT04968509
Effect of PCSK9 Inhibitors on Calcific Aortic Valve Stenosis
Calcific aortic stenosis (CAS) can cause severe adverse cardiac events, but there are currently no effective drugs that can prevent or delay the progression of the disease. In...
Sponsor: Beijing Anzhen HospitalEnrolling: 1601 location
Aortic Stenosis
RECRUITINGNCT07137936
Cardiac Magnetic Resonance - PROgnostic HEart Scar for Sudden Cardiac Death Prediction StudY
The purpose of this observational study is to investigate whether myocardial scar characteristics assessed by cardiac magnetic resonance (CMR) can predict the risk of...
Sponsor: Beijing Anzhen HospitalEnrolling: 10001 location
Sudden Death, CardiacMyocardial ScarringMyocardial Infarction (MI)